Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|6|842-847

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.6, 2015-05, pp. : 842-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication Persistence of Disease‐Modifying Antirheumatic Drugs and Anti–Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil

By  

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1489-1496

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serology and ulcerative colitis behavior

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 64-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 6, 2015-05 ,pp. : 746-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recalcitrant psoriatic uveitis and anti‐tumor necrosis factor‐α monoclonal antibodies: experience from a psoriasis referral center

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 9, 2015-09 ,pp. : 1105-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor‐treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 11-9059, Iss. 10, 2015-10 ,pp. : e442-e445

John Wiley & Sons Inc

Access to resources Recommend Favorite